NAFLD Fibrosis Confirmed to Predict Poor Outcome

<![CDATA[]]>(MedPage Today) — Biopsy-confirmed fibrosis emerged as a key prognostic marker of both mortality and liver-related morbidity in non-alcoholic fatty liver disease (NAFLD) and the patient subgroup with and without non-alcoholic steatohepatitis …

Source link

Related posts

A risk score system to timely manage treatment in Crohn’s disease: a cohort study


Bioengineering functional smooth muscle with spontaneous rhythmic contraction in vitro


Very low prevalence of anti-HAV in Japan: high potential for future outbreak


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy